RVL Pharmaceuticals plc Finite-Lived Intangible Assets, Net
RVL Pharmaceuticals plc had Finite-Lived Intangible Assets, Net of $28.03 million as of 2021-03-31, per its 10-Q filed 2021-05-13.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent › Intangible Asset, Excluding Goodwill, after Accumulated Amortization › Intangible Asset, Finite-Lived, after Accumulated Amortization
us-gaap:FiniteLivedIntangibleAssetsNet · last filed 2021-05-13
- 2021-03-31: Finite-Lived Intangible Assets, Net $28.03M.
- 2020-12-31: Finite-Lived Intangible Assets, Net $30.67M.
- 2020-09-30: Finite-Lived Intangible Assets, Net $53.90M.
- 2020-06-30: Finite-Lived Intangible Assets, Net $77.64M.
| Period end | Finite-Lived Intangible Assets, Net |
|---|---|
| 2021-03-31 | $28.03M 10-Q · filed 2021-05-13 |
| 2020-12-31 | $30.67M 10-K · filed 2021-03-30 |
| 2020-09-30 | $53.90M 10-Q · filed 2020-11-10 |
| 2020-06-30 | $77.64M 10-Q · filed 2020-08-11 |
| 2020-03-31 | $85.62M 10-Q · filed 2020-05-12 |
| 2019-12-31 | $89.99M 10-K · filed 2020-03-19 |
| 2019-09-30 | $125.32M 10-Q · filed 2019-11-14 |
| 2019-06-30 | $266.89M 10-Q · filed 2019-08-08 |
| 2019-03-31 | $409.52M 10-Q · filed 2019-05-09 |
| 2018-12-31 | $406.69M 8-K · filed 2019-12-20 |
| 2018-09-30 | $429.94M 10-Q · filed 2018-11-08 |